ACET Adicet Bio Inc

Price (delayed)

$1.415

Market cap

$116.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.94

Enterprise value

-$111.28M

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta ...

Highlights
The quick ratio has soared by 71% from the previous quarter and by 11% YoY
Adicet Bio's debt has decreased by 15% YoY and by 4.2% QoQ
Adicet Bio's equity has surged by 52% QoQ but it has decreased by 2.8% YoY
The company's net income fell by 33% YoY but it rose by 2% QoQ

Key stats

What are the main financial stats of ACET
Market
Shares outstanding
82.17M
Market cap
$116.28M
Enterprise value
-$111.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.45
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$139.79M
EBITDA
-$130.23M
Free cash flow
-$95.26M
Per share
EPS
-$2.94
Free cash flow per share
-$1.2
Book value per share
$3.15
Revenue per share
$0
TBVPS
$3.71
Balance sheet
Total assets
$293.1M
Total liabilities
$34.29M
Debt
$20.04M
Equity
$258.8M
Working capital
$232.89M
Liquidity
Debt to equity
0.08
Current ratio
14.34
Quick ratio
14.18
Net debt/EBITDA
1.75
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-55.3%
Return on equity
-64.8%
Return on invested capital
-271.6%
Return on capital employed
-50.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
3.28%
1 week
10.55%
1 month
3.28%
1 year
-51.87%
YTD
-25.13%
QTD
16.94%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$149.59M
Net income
-$139.79M
Gross margin
N/A
Net margin
N/A
ACET's operating income is down by 35% YoY
The company's net income fell by 33% YoY but it rose by 2% QoQ

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.45
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS is down by 16% year-on-year but it is up by 11% since the previous quarter
ACET's price to book (P/B) is 69% lower than its 5-year quarterly average of 1.4 and 14% lower than its last 4 quarters average of 0.5
Adicet Bio's equity has surged by 52% QoQ but it has decreased by 2.8% YoY

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE has shrunk by 80% YoY
Adicet Bio's return on assets has shrunk by 73% YoY
Adicet Bio's ROIC has decreased by 46% YoY and by 3.3% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
The quick ratio has soared by 71% from the previous quarter and by 11% YoY
ACET's current ratio has surged by 71% since the previous quarter and by 10% year-on-year
Adicet Bio's debt is 92% lower than its equity
Adicet Bio's equity has surged by 52% QoQ but it has decreased by 2.8% YoY
ACET's debt to equity is down by 33% QoQ and by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.